• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pin1 协调组蛋白去乙酰化酶 6 的上调与肺癌细胞的迁移。

Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Int J Med Sci. 2020 Sep 21;17(17):2635-2643. doi: 10.7150/ijms.50097. eCollection 2020.

DOI:10.7150/ijms.50097
PMID:33162791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7645340/
Abstract

Histone deacetylase 6 (HDAC6) controls many cellular processes via its catalyzing deacetylation of downstream substrates or interacting with its partner proteins. Dysregulation of HDAC6 signaling links to many diseases. Our previous study has been reported peptidyl-prolyl cis/trans isomerase, and NIMA-interacting 1 (Pin1) involving in HDAC6-mediated cell motility. To gain insight into precisely coordination of HDAC6 and Pin1 in cell migration, shRNA-mediated gene silencing and ectopic expression were applied to manipulate protein expression level to evaluate relationship between HDAC6 and Pin1 expression. Quantitative RT-PCR and the cycloheximide (CHX) chase assay resulted in HDAC6 expression is correlated with Pin1 level in H1299 cells. It hints that the Pin1 increases HDAC6 expression through increased transcripts and posttranslational stabilization. Furthermore, wound healing assay and transwell invasion assay evidenced the contribution of Pin1 on cell motility in H1299 cells. Our data suggest that Pin1 acts as an important regulator to manage HDAC6 expression for cell motility in lung cancer cells.

摘要

组蛋白去乙酰化酶 6(HDAC6)通过其对下游底物的催化去乙酰化作用或与伴侣蛋白相互作用来控制许多细胞过程。HDAC6 信号通路的失调与许多疾病有关。我们之前的研究已经报道了肽基脯氨酰顺/反异构酶(Pin1)参与了 HDAC6 介导的细胞运动。为了深入了解 HDAC6 和 Pin1 在细胞迁移中的精确协调,我们应用 shRNA 介导的基因沉默和异位表达来操纵蛋白质表达水平,以评估 HDAC6 和 Pin1 表达之间的关系。定量 RT-PCR 和环己酰亚胺(CHX)追踪实验表明,在 H1299 细胞中,HDAC6 的表达与 Pin1 水平相关。这表明 Pin1 通过增加转录物和翻译后稳定来增加 HDAC6 的表达。此外,划痕愈合实验和 Transwell 侵袭实验证明了 Pin1 对 H1299 细胞运动的贡献。我们的数据表明,Pin1 作为一个重要的调节剂,通过调节 HDAC6 的表达来控制肺癌细胞的运动能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/633edc60e9c7/ijmsv17p2635g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/8dfc50b34707/ijmsv17p2635g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/ecdd0ba786da/ijmsv17p2635g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/a6d387378f41/ijmsv17p2635g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/633edc60e9c7/ijmsv17p2635g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/8dfc50b34707/ijmsv17p2635g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/ecdd0ba786da/ijmsv17p2635g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/a6d387378f41/ijmsv17p2635g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ebf/7645340/633edc60e9c7/ijmsv17p2635g004.jpg

相似文献

1
Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.Pin1 协调组蛋白去乙酰化酶 6 的上调与肺癌细胞的迁移。
Int J Med Sci. 2020 Sep 21;17(17):2635-2643. doi: 10.7150/ijms.50097. eCollection 2020.
2
Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility.Pin1 参与了 HDAC6 介导的癌细胞迁移。
Int J Med Sci. 2018 Oct 20;15(13):1573-1581. doi: 10.7150/ijms.27426. eCollection 2018.
3
G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.G蛋白偶联受体激酶2(GRK2)通过HDAC6-Pin1轴促进乳腺肿瘤发生。
EBioMedicine. 2016 Nov;13:132-145. doi: 10.1016/j.ebiom.2016.09.030. Epub 2016 Oct 1.
4
MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis/trans isomerase.MicroRNA-150-5p 通过调控脯氨酰顺反异构酶抑制人喉表皮样癌细胞的增殖和侵袭。
Braz J Otorhinolaryngol. 2023 May-Jun;89(3):383-392. doi: 10.1016/j.bjorl.2023.03.003. Epub 2023 Mar 13.
5
Isoproterenol increases histone deacetylase 6 expression and cell migration by inhibiting ERK signaling via PKA and Epac pathways in human lung cancer cells.异丙肾上腺素通过蛋白激酶A(PKA)和交换蛋白直接激活因子(Epac)途径抑制细胞外信号调节激酶(ERK)信号传导,从而增加组蛋白去乙酰化酶6的表达并促进人肺癌细胞的迁移。
Exp Mol Med. 2016 Jan 15;48(1):e204. doi: 10.1038/emm.2015.98.
6
Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.肽基脯氨酰顺反异构酶 Pin1 在疾病发病机制中的作用。
Theranostics. 2021 Jan 19;11(7):3348-3358. doi: 10.7150/thno.45889. eCollection 2021.
7
Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.Pin1 表达促进肺癌发生:预后和致癌作用。
Cancer Biol Ther. 2010 Jan;9(2):111-9. doi: 10.4161/cbt.9.2.10341. Epub 2010 Jan 17.
8
Deficiency of microRNA-628-5p promotes the progression of gastric cancer by upregulating PIN1.miR-628-5p 缺失通过上调 PIN1 促进胃癌的进展。
Cell Death Dis. 2020 Jul 23;11(7):559. doi: 10.1038/s41419-020-02766-6.
9
The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.蛋白肽脯氨酰异构酶在脑癌中的多重作用。
Biomolecules. 2018 Oct 11;8(4):112. doi: 10.3390/biom8040112.
10
Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 regulates skeletal muscle fusion through structural modification of Smad3 in the linker region.肽基脯氨酰顺反异构酶 NIMA 相互作用蛋白 1 通过在连接区域对 Smad3 的结构修饰来调节骨骼肌融合。
J Cell Physiol. 2018 Dec;233(12):9390-9403. doi: 10.1002/jcp.26774. Epub 2018 Aug 21.

引用本文的文献

1
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.WT161是一种选择性组蛋白去乙酰化酶6(HDAC6)抑制剂,可抑制黑色素瘤细胞的生长、增强其化学敏感性、促进细胞凋亡并抑制细胞迁移。
Cancer Chemother Pharmacol. 2025 Jan 17;95(1):22. doi: 10.1007/s00280-024-04731-y.
2
The mechanisms of Pin1 as targets for cancer therapy.Pin1作为癌症治疗靶点的作用机制。
Front Immunol. 2024 Nov 18;15:1482088. doi: 10.3389/fimmu.2024.1482088. eCollection 2024.
3
HDAC6: A unique HDAC family member as a cancer target.

本文引用的文献

1
MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.miR-601 通过靶向 HDAC6 抑制食管鳞癌(ESCC)的增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1069-1076. doi: 10.26355/eurrev_201902_16995.
2
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades.过去四十年来肺癌患者的发病率、治疗情况及生存率趋势。
Cancer Manag Res. 2019 Jan 21;11:943-953. doi: 10.2147/CMAR.S187317. eCollection 2019.
3
Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
HDAC6:作为癌症靶点的独特 HDAC 家族成员。
Cell Oncol (Dordr). 2022 Oct;45(5):779-829. doi: 10.1007/s13402-022-00704-6. Epub 2022 Aug 29.
4
FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells.黏着斑激酶通过调控非小细胞肺癌细胞中的EZH2信号传导发挥抗衰老作用。
Biomedicines. 2022 Aug 10;10(8):1937. doi: 10.3390/biomedicines10081937.
5
Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.靶向Pin1调节细胞运动性及癌症治疗
Biomedicines. 2021 Mar 31;9(4):359. doi: 10.3390/biomedicines9040359.
Pin1 抑制通过 Gli1/Snail/E-钙黏蛋白通路逆转人肝癌细胞对瑞戈非尼的获得性耐药。
Cancer Lett. 2019 Mar 1;444:82-93. doi: 10.1016/j.canlet.2018.12.010. Epub 2018 Dec 21.
4
Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility.Pin1 参与了 HDAC6 介导的癌细胞迁移。
Int J Med Sci. 2018 Oct 20;15(13):1573-1581. doi: 10.7150/ijms.27426. eCollection 2018.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Histone deacetylase 6 in cancer.组蛋白去乙酰化酶 6 在癌症中的作用。
J Hematol Oncol. 2018 Sep 3;11(1):111. doi: 10.1186/s13045-018-0654-9.
7
Inhibition of HDAC6 activity in kidney diseases: a new perspective.在肾脏疾病中抑制 HDAC6 活性:一个新视角。
Mol Med. 2018 Jun 26;24(1):33. doi: 10.1186/s10020-018-0027-4.
8
Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.Pin1 通过介导 XPO5 的构象变化来抑制肝癌中的 microRNA 生物发生。
Cell Death Differ. 2018 Sep;25(9):1612-1624. doi: 10.1038/s41418-018-0065-z. Epub 2018 Feb 14.
9
Understanding and targeting resistance mechanisms in NSCLC.了解和靶向非小细胞肺癌的耐药机制。
Nat Rev Cancer. 2017 Oct 25;17(11):637-658. doi: 10.1038/nrc.2017.84.
10
MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.miR-206 通过靶向 HDAC6 抑制 PTEN/AKT/mTOR 通路抑制头颈部鳞状细胞癌细胞的进展。
Biomed Pharmacother. 2017 Dec;96:229-237. doi: 10.1016/j.biopha.2017.08.145. Epub 2017 Oct 6.